Shunrong Li

CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype

Wenfeng Zeng, Lixiong Xiong, Wei Wu et al. · Oncogene · 2022 · 77 citations · Full text

Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer

Jiannan Wu, Shunrong Li, Weijuan Jia et al. · Journal of Cancer Research and Clinical Oncology · 2011 · 58 citations · Full text

Breast Oncology, Medicine, Pathology +7

CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition

Xinwei Liu, Yiwen Lu, Jingying Huang et al. · Cancer Cell · 2022 · 54 citations

Immunology, Antiviral Response, Immunologic Mechanism +9

A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?

Meijun Long, Weijuan Jia, Shunrong Li et al. · Breast Cancer Research and Treatment · 2011 · 52 citations

Oncology, Viral Hepatitis, Cancer Management +9

Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database

Jieqiong Liu, Kai Chen, Wen Jiang et al. · Journal of Cancer Research and Clinical Oncology · 2016 · 52 citations · Full text

National Cancer Database, Breast Oncology, Chemotherapy Response +10